期刊文献+

CN_(0)期甲状腺微小乳头状癌患者发生非小容量中央区淋巴结转移的影响因素 被引量:1

Influencing factors of non-small volume central lymph node metastasis in patients with CN_(0) thyroid micropapillary carcinoma
下载PDF
导出
摘要 目的:分析术前临床淋巴结阴性(CN_(0))甲状腺微小乳头状癌(PTMC)患者发生非小容量中央区淋巴结转移(NSVCLNM)的影响因素。方法:回顾性分析2018年1月至2021年2月该院收治的538例CN_(0)期PTMC患者的临床资料。统计CN_(0)期PTMC患者发生NSVCLNM情况,并采用Logistic回归分析CN_(0)期PTMC患者发生NSVCLNM的影响因素。结果:538例CN_(0)期PTMC患者中,发生NSVCLNM 30例,占5.60%;未发生NSVCLNM 508例,占94.40%。单因素分析结果显示,不同本甲状腺炎情况、BRAFV600E基因情况、BMI、多灶性情况、被膜侵犯情况、AJCC分期患者NSVCLNM发生率比较,差异均无统计学意义(P>0.05);男性、年龄<40岁、双侧癌灶、脉管侵犯、颈侧区淋巴结转移患者的NSVCLNM发生率更高,与其他类别比较,差异均有统计学意义(P<0.05);Logistic回归分析结果显示,男性、年龄<40岁、双侧癌灶、颈侧区淋巴结转移均为影响CN_(0)期PTMC患者发生NSVCLNM的危险因素(OR>1,P<0.05)。结论:男性、年龄<40岁、双侧癌灶、颈侧区淋巴结转移均为影响CN_(0)期PTMC患者发生NSVCLNM的危险因素。 Objective:To analyze influencing factors of non-small volume central lymph node metastasis(NSVCLNM)in patients with preoperative clinical lymph node negative(CN_(0))thyroid micropapillary carcinoma(PTMC).Methods:The clinical data of 538 patients with CN_(0) PTMC admitted to the hospital from January 2018 to February 2021 were retrospectively analyzed.The incidence of NSVCLNM in the patients with CN_(0) PTMC was statistically analyzed.Logistic regression analysis was used to analyze the influencing factors of NSVCLNM in the patients with CN_(0) PTMC.Results:Of the 538 patients with CN_(0) PTMC,30 had NSVCLNM,accounting for 5.60%,and were set as occurrence group;508 cases had no NSVCLNM,accounting for 94.40%,and were set as non-occurrence group.Univariate analysis showed that there were no significant difference in the incidence of NSVCLNM in patients with different thyroid inflammation,BRAFV600E gene,BMI,multifocality,capsule invasion and AJCC stage(P>0.05).The incidence of NSVCLNM were higher in patients with male,age<40 years,bilateral cancer,vascular invasion,and lateral cervical lymph node metastasis,and the difference were statistically significant compared with other categories(P<0.05).Logistic regression analysis showed that male,age<40 years old,bilateral tumor,and lateral cervical lymph node metastasis were all risk factors for NSVCLNM in the PTMC patients(OR>1,P<0.05).Conclusions:Male,age<40 years old,bilateral tumor,and lateral cervical lymph node metastasis are the risk factors for NSVCLNM in the PTMC patients.
作者 崔晓云 王俊 CUI Xiaoyun;WANG Jun(Thyroid Surgery of the First Affiliated Hospital of Jinzhou Medical University,Jinzhou 121000 Liaoning,China)
出处 《中国民康医学》 2023年第11期7-10,共4页 Medical Journal of Chinese People’s Health
关键词 甲状腺微小乳头状癌 临床淋巴结阴性 非小容量中央区淋巴结转移 Thyroid micropapillary carcinoma Clinical negative lymph node Non-small volume central lymph node metastasis
  • 相关文献

参考文献4

二级参考文献60

  • 1American Thyroid Association (ATA) Guidelines Taskforce on Thy- roid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al. Revised American thyroid association manage- ment guidelines for patients with thyroid nodules and differentiat- ed thyroid cancer[J]. Thyroid, 2009, 19(11):1167-1214.
  • 2Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid as- sociation management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid as- sociation guidelines task force on thyroid nodules and differentiat- ed thyroid cancer[J]. Thyroid, 2016, 26(1):1-133.
  • 3Tuttle RM, Haddad RI, Ball DW, et al. Thyroid carcinoma, version 2.2014[J]. J Natl Compr Canc Netw, 2014, 12(12):1671-1680.
  • 4Xing MZ. Molecular pathogenesis and mechanisms of thyroid can- cer[J]. Nat Rev Cancer, 2013, 13(3):184-199.
  • 5De Biase D, Gandolfi G, Ragazzi M, et al. TERT promoter mutations in papillary thyroid microcarcinomas[J]. Thyroid, 2015, 25(9):1013- 1019.
  • 6Ito Y, Miyauchi A, Inoue H, et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients[J]. World J Surg, 2010, 34(1):28-35.
  • 7Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid [J]. Thyroid, 2003, 13(4):381-387.
  • 8Xing M, Alzahrani AS, Carson KA, et al. Association between BRAF V600E mutation and recurrence of papillary thyroid cancer[J]. J Clin Oncol, 2015, 33(1):42-50.
  • 9Jiang LH, Chen C, Tan Z, et al. Clinical characteristics related to central lymph node metastasis in cN0 papillary thyroid carcinoma: a retro- spective study of 916 patients[J]. Int J Endocrinol, 2014, 2014:385787.
  • 10Ito Y, Fukushima M, Higashiyama T, et al. Tumor size is the strongest predictor of microscopic lymph node metastasis and lymph node recurrence of NO papillary thyroid carcinoma[J]. Endocr J, 2013, 60 (1):113-117.

共引文献421

同被引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部